Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

WP2 - Biomarker discovery in observational prospective studies

WP leaders

Charlotte Ling and Hindrik Mulder


  • To identify and validate new biomarkers for early onset of disease
  • To identify and validate new biomarkers from and applicable to, broad populations in order to predict desease progression (including complications), as well as to explore whether these biomarkers are enriched in some to the new clusters obtained by using a more fine-tuned diabetes classification
  • To identify and validate new biomarkers of efficacy response, including dynamic biomarkers that change with interventions (i.e. experimental therapeutic, Standard of Care, life style interventions)

Lund University Diabetes Centre, CRC, SUS Malmö, Jan Waldenströms gata 35, House 91:12. SE-214 28 Malmö. Telephone: +46 40 39 10 00